Nuage Therapeutics obtains €2.7 million to develop a pioneering treatment against the most aggressive lung cancer

by Parc Científic de Barcelona

A public-private consortium led by the biotechnology company Nuage Therapeutics has initiated the development of an innovative therapy against the most frequent subtype of small cell lung cancer (SCLC...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream